StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.42+0.20 (+6.21%)

Close on Nov 18, 2026Market cap $43.94MP/E –Yield –

Clene revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Clene's revenue for the twelve months ending Jun 30, 2026 was $197.00K, down 31.1% year over year. For fiscal 2025 it was $200.00K, down 41.5% from the year before. The highest annual figure on record is $723.00K in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$200.00K-41.5%
FY2024Dec 31, 2024$342.00K-47.7%
FY2023Dec 31, 2023$654.00K+38.3%
FY2022Dec 31, 2022$473.00K-34.6%
FY2021Dec 31, 2021$723.00K+251.0%
FY2020Dec 31, 2020$206.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$90.00K+233.3%
Q1 FY2026Mar 31, 2026$15.00K-81.5%
Q4 FY2025Dec 31, 2025$77.00K-15.4%
Q3 FY2025Sep 30, 2025$15.00K-82.8%
Q2 FY2025Jun 30, 2025$27.00K-70.3%
Q1 FY2025Mar 31, 2025$81.00K+11.0%
Q4 FY2024Dec 31, 2024$91.00K-46.5%
Q3 FY2024Sep 30, 2024$87.00K-19.4%
Q2 FY2024Jun 30, 2024$91.00K-66.2%
Q1 FY2024Mar 31, 2024$73.00K-31.8%
Q4 FY2023Dec 31, 2023$170.00K+385.7%
Q3 FY2023Sep 30, 2023$108.00K+260.0%
Q2 FY2023Jun 30, 2023$269.00K+35.2%
Q1 FY2023Mar 31, 2023$107.00K-2.7%
Q2 FY2022Jun 30, 2022$35.00K-82.6%
Q1 FY2022Mar 31, 2022$30.00K-85.9%
Q4 FY2021Dec 31, 2021$199.00K+586.2%
Q3 FY2021Sep 30, 2021$110.00K+12.2%
Q2 FY2021Jun 30, 2021$201.00K+2133.3%
Q1 FY2021Mar 31, 2021$213.00K+204.3%
Q4 FY2020Dec 31, 2020$29.00K–
Q3 FY2020Sep 30, 2020$98.00K–
Q2 FY2020Jun 30, 2020$9.00K–
Q1 FY2020Mar 31, 2020$70.00K–

More Clene figures

See a number that looks wrong?